Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
Silence Therapeutics (SLN)
Share Price: 211.75p Change Today: 0.25p  Market Cap: 110.11m

SLN Overview

Silence Therapeutics is in the pharmaceuticals & biotechnology sector and is currently trading at 211.75p per share. In the last year Silence Therapeutics's share price has ranged from 195.00p to 375.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

6 Month Chart

SLN Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-09 1.72 (7.51) (246.59)p n/a n/a n/a n/a 0.0%
31-Dec-10 2.37 (8.80) (140.40)p n/a n/a n/a n/a 0.0%
31-Dec-11 0.69 (5.74) (56.17)p n/a n/a n/a n/a 0.0%
31-Dec-12 0.16 (26.28) (6,750.00)p n/a n/a n/a n/a 0.0%
31-Dec-13 0.12 (9.00) (20.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SLN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 n/a (12.90) (25.50)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.00) (17.30)p n/a n/a n/a n/a 0.0%

Copyright © 2014 FactSet Research Systems Inc. All rights reserved.

SLN Company Announcements

Board change 02-Sep-2014 09:05 RNS
Notice of Results 27-Aug-2014 15:38 RNS
Licensee confirms favourable trial outcome 30-Jul-2014 07:00 RNS

Latest SLN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Price Data

Currency UK Pounds
Share Price 211.75p
Change Today 0.25p
% Change 0.12 %
Volume 39,248
02-Sep-14 Close 211.75p
Shares Issued 52.00m
Market Cap 110.11m
Year End 31-Dec-13

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SLN Dividends

No dividends found

Trades for 02-Sep-2014

Time Volume / Share Price
16:35 948 @ 211.75p
15:55 850 @ 211.75p
14:12 2,000 @ 214.00p
14:12 1,400 @ 214.75p
14:12 2,350 @ 215.04p

SLN Key Personnel

Finance Director Tim Freeborn
CEO Ali Mortazavi
Chair Simon Sturge


www.bolsamania.com www.sharecast.com http://www.proshareclubs.co.uk/ www.digitallook.com